Tri Dinh, MD
Gynecologic Oncology · Jacksonville, FLNPI 1619986932
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,000 of the $7,992 with a category attached, or 75.1%. Distalmotion US accounts for 81.1% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2024 at $6,593 and has fallen 97.4% since, to $174 in 2025.
Across 22 payments — averaging $363.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Distalmotion US$6K
- Biom'up SA$286
- Davol Inc.$138
- Caris MPI, Inc.$130
- Regeneron$118
- Eisai Inc.$111
- plus $725 from 10 others
Across 3 payments — averaging $11,578 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$35K
What the payments were for
- Consulting fees$6,00075%
- Travel & lodging$5116%
- Food & beverage$1,33817%
- Education$1432%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Distalmotion US | 3 | $6,484 |
| Biom'up SA | 2 | $286 |
| Davol Inc. | 1 | $138 |
| Caris MPI, Inc. | 1 | $130 |
| Regeneron | 2 | $118 |
| Eisai Inc. | 2 | $111 |
| Boston Scientific | 1 | $108 |
| Aadi Bioscience, Inc. | 1 | $100 |
| Hologic Sales And Service, LLC | 1 | $93 |
| Applied Medical Resources Corporation | 1 | $85 |
| Minerva Surgical, Inc | 1 | $83 |
| Seagen Inc. | 1 | $65 |
| Genentech USA, Inc. | 1 | $64 |
| Intuitive Surgical | 2 | $58 |
| AstraZeneca | 1 | $43 |
| Mentor Worldwide LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXTER L6 ROBOT$6,426
- HEMOBLAST$286
- ARISTA AH FLEXITIP$138
- MI CANCER SEEK$130
- CYTUITY$108
How this compares
$7,992 in reported general payments places this provider in the 70th percentile of 117 gynecologic oncology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 46 | $3,617 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Jacksonville
- Martin MartinoJacksonville$957K
- Jenny WhitworthJacksonville$7K
- Matthew RobertsonJacksonville$6K
- Bradley MonkWest Palm Beach$2.5M
- Brian SlomovitzFort Lauderdale$519K
- Ricardo EstapeMiami$457K
- Robert HollowayOrlando$432K
- Shelly SewardOrlando$349K
- Edward GrendysFort Myers$341K
- Jonathan BlackMiramar$329K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.